EICHORPublic-registry site landscape for NCT04832425, “A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder”, a Major Depressive Disorder study sponsored by Praxis Precision Medicines. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04832425 (registry record) |
| Study title | A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder |
| Official title | A Phase 2/3 Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Major Depressive Disorder |
| Sponsor | Praxis Precision Medicines |
| Condition(s) | Major Depressive Disorder |
| Phase | PHASE2 / PHASE3 |
| Listed sites | 31 |
| Site countries | United States, Australia |
Patient-friendly overview of this study: eichor.com/study/NCT04832425.
Eichor generates a preliminary site-risk snapshot for NCT04832425 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Major Depressive Disorder trials
More from Praxis Precision Medicines
← Eichor home · All tracked trials · Major Depressive Disorder studies · Weekly briefs
